SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-014027
Filing Date
2022-08-03
Accepted
2022-08-03 09:06:46
Documents
14
Period of Report
2022-08-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20220803.htm   iXBRL 8-K 54269
2 EX-99.1 hcwb-ex99_1.htm EX-99.1 23876
3 GRAPHIC img90053791_0.jpg GRAPHIC 46853
  Complete submission text file 0000950170-22-014027.txt   264131

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hcwb-20220803_pre.xml EX-101.PRE 9840
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hcwb-20220803.xsd EX-101.SCH 2469
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hcwb-20220803_lab.xml EX-101.LAB 13342
8 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20220803_htm.xml XML 4700
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

IRS No.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 221131102
SIC: 2834 Pharmaceutical Preparations